Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 6217 - 6224 of 12104 results

USCIS Reaches Statutory Limit of H-1B Cap Cases for Fiscal Year 2019

April 6, 2018| Alert| Viewpoint

District Court Grants Protection under DTSA Whistleblower Immunity for First Time

April 6, 2018| Blog| Viewpoint

MA Pregnant Workers Fairness Act: Part II

April 5, 2018| Blog| Viewpoint

WesternGeco v. ION Geophysical Corp. and Lost Profit Damages under § 271(f)

April 5, 2018| Blog| Viewpoint

MedPAC Recommends Significant Changes to MACRA

April 5, 2018| Blog| Viewpoint

Alabama Enacts Data Breach Notification Law

April 5, 2018| Blog| Viewpoint

The California Attorney General and Sutter Health Face Off in an Antitrust Lawsuit

April 5, 2018| Blog| Viewpoint

News & Press Releases

Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree

August 19, 2025

Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.

Mintz Advises Underwriters in Assembly Biosciences' $175 Million Underwritten Offering and Concurrent Private Placement

August 18, 2025

Mintz advised the underwriters in connection with Assembly Biosciences, Inc.’s underwritten offering of an aggregate of 5,591,840 shares of common stock and pre-funded warrants to purchase up to 1,040,820 shares of common stock, together with accompanying Class A and Class B warrants to purchase up to an aggregate of 6,632,660 shares of common stock at a combined price per share of common stock and accompanying Class A warrant and Class B warrant of $19.60 and a combined price per pre-funded warrant and accompanying Class A warrant and Class B warrant of $19.599.

Mintz Advises the Underwriters in Ondas Holdings’ $173 Million Public Offering

August 18, 2025

Mintz advised the underwriters in connection with the $173 million public offering by Ondas Holdings Inc. of 53,084,000 shares of its common stock, which includes 6,924,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock.

View all News and Press Releases